Stefanie Aust - Gynecology

Author Information

Stefanie Aust is affiliated with the Department of Obstetrics and Gynecology, Comprehensive Cancer Center (CCC), Medical University of Vienna, located in Vienna, Austria. Her research primarily focuses on gynecologic oncology, contributing significant insights into ovarian and endometrial cancers.

Research Contributions

Stefanie Aust has made substantial contributions to the field of gynecology, particularly in the area of ovarian cancer. Her research spans various topics, including biomarker-based models for preoperative assessment, molecular profiling for cancer treatment, and the study of tumor-associated neovasculature. Notable papers include studies on the expression of Prostate-Specific Membrane Antigen (PSMA) in ovarian cancer and the risk reclassification of endometrial cancer based on tumor molecular profiling.

Aliases

S Aust, S. Aust, Stefanie Aust

Publication and Citation Metrics

Metric	Value
Citation Count	1830
h-index	21
Paper Count	70

Publications:

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study

DOI: 10.3390/cancers14071780

Year: 2022

Prostate-Specific Membrane Antigen (PSMA) Expression in Tumor-Associated Neovasculature Is an Independent Prognostic Marker in Patients with Ovarian Cancer

DOI: 10.3390/jpm12040551

Year: 2022

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium

DOI: 10.3390/cancers13235865

Year: 2021

PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome

DOI: 10.1038/s41598-021-85966-0

Year: 2021

Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

DOI: 10.3390/jpm11010048

Year: 2021

Detailed overview on rare malignant ovarian tumors.

DOI: 10.1016/j.bulcan.2020.01.011

Year: 2020

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real‐World Precision Cancer Medicine Platform

DOI: 10.1634/theoncologist.2019-0904

Year: 2020

Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI

DOI: 10.3390/jpm10040188

Year: 2020

Screening for ovarian cancer: is there still hope?

DOI: 10.1007/s12254-019-00563-2

Year: 2020

Arcagen: Molecular profiling of rare cancer patients – analysis of the pilot study (87 patients)

DOI: 10.1016/s0959-8049(20)31155-2

Year: 2020

How is Female Infertility Treated?

How does sexual health relate to self-esteem in gynecology?

How Can Healthcare Providers Support These Groups?

How do you identify and treat urinary incontinence?

What is Reproductive Endocrinology?

What Does Operator Dependent Mean in Gynecology?

What are the Key Measurements in Clinical Pelvimetry?

How Often Should Prenatal Visits Occur?

How Do Cataracts Impact Pregnancy?

What is Hepatitis B Surface Antigen (HBsAg)?

Partnered Content Networks

Relevant Topics